Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinical characteristics and efficacy analysis of 11 patients with primary cutaneous diffuse large B-cell lymphoma, leg type]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37803847 | PubTator, text mining | PubMed |
| Mouse methylation profiles for leukocyte cell types, and estimation of leukocyte fractions in inflamed gastrointestinal DNA samples. | PLoS One | 2023 | 37797047 | PubTator, text mining | PubMed |
| De novo dedifferentiated SDH-deficient gastrointestinal stromal tumor with MDM2 amplification: case report and literature review. | Front Oncol | 2023 | 37781202 | PubTator, text mining | PubMed |
| Nature and nurture: understanding phenotypic variation in inborn errors of immunity. | Front Cell Infect Microbiol | 2023 | 37780853 | PubTator, text mining | PubMed |
| The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects. | Int J Mol Sci | 2023 | 37762410 | PubTator, text mining | PubMed |
| Analytical Performance of a Novel Latex Turbidimetric Immunoassay, "Nanopia TARC", for TARC/CCL17 Measurement: A Retrospective Observational Study. | Diagnostics (Basel) | 2023 | 37761302 | PubTator, text mining | PubMed |
| The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia-A Review of Current Knowledge. | Diagnostics (Basel) | 2023 | 37761258 | PubTator, text mining | PubMed |
| Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach. | Cancers (Basel) | 2023 | 37760453 | PubTator, text mining | PubMed |
| Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies-A Systematic Review. | Cancers (Basel) | 2023 | 37760410 | PubTator, text mining | PubMed |
| Atopic manifestations of inborn errors of immunity. | Curr Opin Allergy Clin Immunol | 2023 | 37755421 | PubTator, text mining | PubMed |
| Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment. | Front Oncol | 2023 | 37746258 | PubTator, text mining | PubMed |
| Hyper IgE syndrome-related disease treated with dupilumab: A case report. | Clin Case Rep | 2023 | 37720709 | PubTator, text mining | PubMed |
| Extranodal lymphoma: pathogenesis, diagnosis and treatment. | Mol Biomed | 2023 | 37718386 | PubTator, text mining | PubMed |
| Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organ. | Cancer Med | 2023 | 37706649 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing identifies distinct transcriptomic signatures between PMA/ionomycin- and αCD3/αCD28-activated primary human T cells. | Genomics Inform | 2023 | 37704208 | PubTator, text mining | PubMed |
| Role of non-Helicobacter pylori gastric Helicobacters in helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma. | World J Gastroenterol | 2023 | 37701138 | PubTator, text mining | PubMed |
| Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma. | iScience | 2023 | 37694148 | PubTator, text mining | PubMed |
| FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes. | JID Innov | 2023 | 37674691 | PubTator, text mining | PubMed |
| Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement. | Front Immunol | 2023 | 37671152 | PubTator, text mining | PubMed |
| Generation of inactivated IL2RG and RAG1 monkeys with severe combined immunodeficiency using base editing. | Signal Transduct Target Ther | 2023 | 37661226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=10